What to check before you switch
Before moving any volume, confirm that switching ordering platforms does not disrupt the pharmacy layer underneath. First, check formulary coverage: list your highest-volume SKUs — semaglutide, tirzepatide, your hormone and peptide lines — and confirm the LegitScript-certified 503A partners assigned to your Fizy Health clinic can fill them. Wells Pharmacy Network is the compounder for your current orders; Fizy Health routes to a different set of assigned compounders, so coverage is the first thing to verify before you shift a single patient.
Second, review your existing Wells Pharmacy Network account terms for any notice period, minimum commitment, or termination requirements before you reduce volume — these are clinic-specific details you should read in your own agreement rather than assume. Third, decide what you carry over: patient demographics, your common SIGs, and your repeat-order SKUs. If 503B office-use bulk dispensing through Wells is part of your workflow, confirm whether you still need that capacity alongside Fizy Health's patient-specific 503A routing — the two paths can coexist. None of this requires an EMR migration — WellsPx3 and Fizy Health live alongside your chart system, not in place of it.